TY  - CONF
AU  - Milijić Petrović, Valentina
AU  - Marković, Mirjana
AU  - Pavlović, Dragana
AU  - Buha-Đorđević, Aleksandra
AU  - Popović, Ivana
AU  - Anđelković, Jasna
AU  - Stojkov, Svetlana
AU  - Gigov, Slobodan
AU  - Drenić, Dušan
PY  - 2022
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4553
AB  - Exact number of masters of pharmacy, level of their education, and jobs they are
engaged in is not known in Serbia. The number of pharmacists employed in health
institutions in Serbia is known (data is regularly updated by Pharmaceutical Chamber of
Serbia (FCC) because pharmacists must be licensed and registered). According to the FCC, in
Serbia, there are 6,814 Masters of Pharmacy licensed to work in healthcare institutions (1).
However, their arrangement and number by pharmacy, type and level of services are
unknown. Although all health institutions are now obliged to register through Business
Registers Agency (2), actual number of pharmacies and number of responsible pharmacists
per pharmacy remained invisible. The big question is whether all masters of pharmacy are
aware of their legal obligations, responsibilities, and professional opportunities. The number
of masters of pharmacy employed in other sectors is completely unknown. There is no
register of colleagues with completed health and academic specializations, master and
doctoral studies. The legal opportunity to acquire title of subspecialist in pharmacy should
be used and enable further training and recognition of work to colleagues who deal with
narrowly specialized pharmaceutical jobs. Funds for creating database of pharmacists (who
they are, what positions they hold, and what their level of education is) are minimal. It is only
necessary to recognize the importance of such database and connect key stakeholders. The
intersection of current situation would enable development and improvement of
pharmaceutical profession and would be step forward towards modernization of Serbian
health care system.
AB  - U Srbiji nije poznat precizan broj magistara farmacije, stepen njihovog
poslediplomskog obrazovanja i radna mesta na kojima su angažovani. Broj farmaceuta
zaposlenih u zdravstvenim ustanovama u Srbiji je poznat (podatke redovno ažurira
Farmaceutska komora Srbije (FKS), jer farmaceuti moraju imati licencu i moraju biti upisani
u FKS). Prema podacima FKS u Srbiji 6.814 magistara farmacije poseduje licencu za rad u
zdravstvenim ustanovama (1). Ipak, njihov raspored i broj po apotekama, vrsta i nivoi
njihovih usluga su nepoznati. Nakon promene zakonske regulative, sada sve zdavstvene
ustanove imaju obavezu da se registruju preko Agencije za privredne registre (2), i dalje je
ostao nevidljiv stvaran broj apoteka i odgovornih farmaceuta po svakoj apoteci. Veliko je
pitanje i da li su svi magistri farmacije svesni svojih zakonskih obaveza, odgovornosti i
profesionalnih mogućnosti. Broj magistara farmacije zaposlenih u ostalim sektorima je
potpuno nepoznat. Ne postoji ni registar kolega sa završenim zdravstvenim i akademskim
specijalizacijama, magistarskim i doktorskim studijama. Zakonsku mogućnost za sticanje
zvanja subspecijalista u farmaciji treba iskoristiti i omogućiti dalje usavršavanje i
priznavanje rada kolegama koji se bave uskostručnim farmaceutskim poslovima (npr.
onkološka farmacija). Sredstva za izradu baze farmaceuta (ko su, na kojim pozicijama rade i
kog su nivoa obrazovanja) su minimalna, a ljudski resursi već postoje. Potrebno je samo
prepoznati važnost ovakve baze i povezati ključne zainteresovane strane (FKS, Privrednu
komoru Srbije, akademiju, Savez farmaceutskih udruženja Srbije, farmaceutsku industriju).
Presek zatečenog stanja putem baze farmaceuta bi omogućio dalji razvoj i unapređenje
farmaceutske struke, i bio bi korak napred ka modernizaciji zdravstvenog sistema Srbije.
PB  - Savez farmaceutskih udruženja Srbije (SFUS)
C3  - Arhiv za farmaciju
T1  - Why do we need a pharmacist database and a reminder of the pharmacist’s job description?
T1  - Zašto nam je potrebna baza farmaceuta i podsećanje na opis poslova magistra farmacije?
VL  - 72
IS  - 4 suplement
SP  - S345
EP  - S346
UR  - https://hdl.handle.net/21.15107/rcub_farfar_4553
ER  - 

@conference{
author = "Milijić Petrović, Valentina and Marković, Mirjana and Pavlović, Dragana and Buha-Đorđević, Aleksandra and Popović, Ivana and Anđelković, Jasna and Stojkov, Svetlana and Gigov, Slobodan and Drenić, Dušan",
year = "2022",
abstract = "Exact number of masters of pharmacy, level of their education, and jobs they are
engaged in is not known in Serbia. The number of pharmacists employed in health
institutions in Serbia is known (data is regularly updated by Pharmaceutical Chamber of
Serbia (FCC) because pharmacists must be licensed and registered). According to the FCC, in
Serbia, there are 6,814 Masters of Pharmacy licensed to work in healthcare institutions (1).
However, their arrangement and number by pharmacy, type and level of services are
unknown. Although all health institutions are now obliged to register through Business
Registers Agency (2), actual number of pharmacies and number of responsible pharmacists
per pharmacy remained invisible. The big question is whether all masters of pharmacy are
aware of their legal obligations, responsibilities, and professional opportunities. The number
of masters of pharmacy employed in other sectors is completely unknown. There is no
register of colleagues with completed health and academic specializations, master and
doctoral studies. The legal opportunity to acquire title of subspecialist in pharmacy should
be used and enable further training and recognition of work to colleagues who deal with
narrowly specialized pharmaceutical jobs. Funds for creating database of pharmacists (who
they are, what positions they hold, and what their level of education is) are minimal. It is only
necessary to recognize the importance of such database and connect key stakeholders. The
intersection of current situation would enable development and improvement of
pharmaceutical profession and would be step forward towards modernization of Serbian
health care system., U Srbiji nije poznat precizan broj magistara farmacije, stepen njihovog
poslediplomskog obrazovanja i radna mesta na kojima su angažovani. Broj farmaceuta
zaposlenih u zdravstvenim ustanovama u Srbiji je poznat (podatke redovno ažurira
Farmaceutska komora Srbije (FKS), jer farmaceuti moraju imati licencu i moraju biti upisani
u FKS). Prema podacima FKS u Srbiji 6.814 magistara farmacije poseduje licencu za rad u
zdravstvenim ustanovama (1). Ipak, njihov raspored i broj po apotekama, vrsta i nivoi
njihovih usluga su nepoznati. Nakon promene zakonske regulative, sada sve zdavstvene
ustanove imaju obavezu da se registruju preko Agencije za privredne registre (2), i dalje je
ostao nevidljiv stvaran broj apoteka i odgovornih farmaceuta po svakoj apoteci. Veliko je
pitanje i da li su svi magistri farmacije svesni svojih zakonskih obaveza, odgovornosti i
profesionalnih mogućnosti. Broj magistara farmacije zaposlenih u ostalim sektorima je
potpuno nepoznat. Ne postoji ni registar kolega sa završenim zdravstvenim i akademskim
specijalizacijama, magistarskim i doktorskim studijama. Zakonsku mogućnost za sticanje
zvanja subspecijalista u farmaciji treba iskoristiti i omogućiti dalje usavršavanje i
priznavanje rada kolegama koji se bave uskostručnim farmaceutskim poslovima (npr.
onkološka farmacija). Sredstva za izradu baze farmaceuta (ko su, na kojim pozicijama rade i
kog su nivoa obrazovanja) su minimalna, a ljudski resursi već postoje. Potrebno je samo
prepoznati važnost ovakve baze i povezati ključne zainteresovane strane (FKS, Privrednu
komoru Srbije, akademiju, Savez farmaceutskih udruženja Srbije, farmaceutsku industriju).
Presek zatečenog stanja putem baze farmaceuta bi omogućio dalji razvoj i unapređenje
farmaceutske struke, i bio bi korak napred ka modernizaciji zdravstvenog sistema Srbije.",
publisher = "Savez farmaceutskih udruženja Srbije (SFUS)",
journal = "Arhiv za farmaciju",
title = "Why do we need a pharmacist database and a reminder of the pharmacist’s job description?, Zašto nam je potrebna baza farmaceuta i podsećanje na opis poslova magistra farmacije?",
volume = "72",
number = "4 suplement",
pages = "S345-S346",
url = "https://hdl.handle.net/21.15107/rcub_farfar_4553"
}

Milijić Petrović, V., Marković, M., Pavlović, D., Buha-Đorđević, A., Popović, I., Anđelković, J., Stojkov, S., Gigov, S.,& Drenić, D.. (2022). Why do we need a pharmacist database and a reminder of the pharmacist’s job description?. in Arhiv za farmaciju
Savez farmaceutskih udruženja Srbije (SFUS)., 72(4 suplement), S345-S346.
https://hdl.handle.net/21.15107/rcub_farfar_4553

Milijić Petrović V, Marković M, Pavlović D, Buha-Đorđević A, Popović I, Anđelković J, Stojkov S, Gigov S, Drenić D. Why do we need a pharmacist database and a reminder of the pharmacist’s job description?. in Arhiv za farmaciju. 2022;72(4 suplement):S345-S346.
https://hdl.handle.net/21.15107/rcub_farfar_4553 .

Milijić Petrović, Valentina, Marković, Mirjana, Pavlović, Dragana, Buha-Đorđević, Aleksandra, Popović, Ivana, Anđelković, Jasna, Stojkov, Svetlana, Gigov, Slobodan, Drenić, Dušan, "Why do we need a pharmacist database and a reminder of the pharmacist’s job description?" in Arhiv za farmaciju, 72, no. 4 suplement (2022):S345-S346,
https://hdl.handle.net/21.15107/rcub_farfar_4553 .

TY  - CONF
AU  - Anđelković, Jasna
AU  - Kovačević, Milena
AU  - Miljković, Branislava
PY  - 2022
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4393
AB  - Primena direktnih oralnih antikoagulanasa (DOAK) kod starijih pacijenta nosi veći
rizik od krvarenja, ali i od tromboembolijskih događaja, u poređenju sa mlađim pacijentima.
Cilj istraživanja bila je identifikacija terapijskih problema i intervencija farmaceuta na
primarnom nivou zdravstvene zaštite. U Apoteci Kragujevac u periodu 2019-2022. godine
sprovedeno je prospektivno istraživanje koje je uključilo pacijente starosti ≥65 godina koji
su primenjivali DOAK. Za potrebe istraživanja kreiran je upitnik koji je popunjavan u toku
razgovora sa pacijentom. Istraživanjem je obuhvaćeno 78 pacijenata, prosečne starosti 71±8
godina, od kojih su 68% bili muškarci. Pacijenti su u proseku imali 3±1 dijagnoze i 5±2
lekova u terapiji. Apiksaban je koristilo 44%, rivaroksaban 31%, dabigatran 25%. Indikacije
za primenu bile su atrijalna fibrilacija 59% i venski tromboembolizam 41%. Uočena su 102
terapijska problema. Skoro četvrtina pacijenata (24%) nije ispravno primenjivala lek (npr.
uzimanje rivaroksabana našte bez hrane, otvaranje dabigatran kapsula), 38% imalo je
problem sa adherencom, 12% primenjivalo je nisku doza leka, 9% visoku dozu leka, dok su
potencijalne interakcije bile prisutne kod 41%. Od značajnih faktora rizika, 23% pacijenata
imalo je nestabilan krvni pritisak, 33% nije obavešteno o značaju praćenja renalne funkcije
tokom primene leka, i jedan pacijent je imao nizak nivo hemoglobina. Dva pacijenta su
upućena lekaru, od kojih je jedan imao epizodu krvarenja. Farmaceuti su sve pacijente
edukovali o važnosti adherence i pravilnoj primeni DOAK i obavešteni su o značaju
posedovanja kartice sa upozorenjima. Rezultati pokazuju neophodnost monitoringa primene
DOAK kod pacijenata ≥65 godina sprovođenjem standardizovane farmaceutske usluge na
primarnom nivou zdravstvene zaštite.
AB  - The use of direct oral anticoagulants (DOACs) in older patients carries a higher risk of
both thromboembolic events and anticoagulant-associated bleeding, in comparison to
younger patients. The aim of this study was to identify drug-related problems (DRPs) and
pharmacists’ interventions related to DOACs. A prospective survey was conducted at
Pharmacy Kragujevac from 2019 to 2022. Data were obtained for patients aged ≥65 with
DOACs prescription, using a questionnaire that was filled out during a conversation with the
patient. The study included 78 patients, aged 71±8 years, 68% of whom were men. On
average, patients had 3±1 diagnoses and 5±2 medications. Apixaban was used by 44%,
rivaroxaban 31%, dabigatran 25%. Atrial fibrillation was present in 59% and deep vein
thrombosis in 41%. A total of 102 DRPs were detected: inappropriate drug use in 24% (e.g.
taking rivaroxabane without food, opening dabigatran capsules), adherence in 38%, low
dose in 12%, high dose in 9%, while potential interactions were present in 41%. Among the
significant risk factors, 23% had unstable blood pressure, 33% were not informed about the
importance of renal function monitoring during the drug use, and one patient had low
hemoglobin level. Two patients were referred to a doctor, one of whom had an episode of
bleeding. Pharmacists educated all the patients about the importance of adherence, proper
application of DOACs and the importance of DOACs alert card. The results demonstrate the
necessity of monitoring the use of DOACs in elderly patients by implementing standardized
pharmaceutical services at the primary level of health care.
PB  - Savez farmaceutskih udruženja Srbije (SFUS)
C3  - Arhiv za farmaciju
T1  - Značaj monitoringa primene direktnih oralnih antikoagulanasa kod starijih pacijenata u apotekama javnog tipa u Srbiji
T1  - Importance of monitoring the use of direct oral anticoagulants in older patients in community pharmacies in Serbia
VL  - 72
IS  - 4 Suplement
SP  - S270
EP  - S271
EP  - S270
UR  - https://hdl.handle.net/21.15107/rcub_farfar_4393
ER  - 

@conference{
author = "Anđelković, Jasna and Kovačević, Milena and Miljković, Branislava",
year = "2022",
abstract = "Primena direktnih oralnih antikoagulanasa (DOAK) kod starijih pacijenta nosi veći
rizik od krvarenja, ali i od tromboembolijskih događaja, u poređenju sa mlađim pacijentima.
Cilj istraživanja bila je identifikacija terapijskih problema i intervencija farmaceuta na
primarnom nivou zdravstvene zaštite. U Apoteci Kragujevac u periodu 2019-2022. godine
sprovedeno je prospektivno istraživanje koje je uključilo pacijente starosti ≥65 godina koji
su primenjivali DOAK. Za potrebe istraživanja kreiran je upitnik koji je popunjavan u toku
razgovora sa pacijentom. Istraživanjem je obuhvaćeno 78 pacijenata, prosečne starosti 71±8
godina, od kojih su 68% bili muškarci. Pacijenti su u proseku imali 3±1 dijagnoze i 5±2
lekova u terapiji. Apiksaban je koristilo 44%, rivaroksaban 31%, dabigatran 25%. Indikacije
za primenu bile su atrijalna fibrilacija 59% i venski tromboembolizam 41%. Uočena su 102
terapijska problema. Skoro četvrtina pacijenata (24%) nije ispravno primenjivala lek (npr.
uzimanje rivaroksabana našte bez hrane, otvaranje dabigatran kapsula), 38% imalo je
problem sa adherencom, 12% primenjivalo je nisku doza leka, 9% visoku dozu leka, dok su
potencijalne interakcije bile prisutne kod 41%. Od značajnih faktora rizika, 23% pacijenata
imalo je nestabilan krvni pritisak, 33% nije obavešteno o značaju praćenja renalne funkcije
tokom primene leka, i jedan pacijent je imao nizak nivo hemoglobina. Dva pacijenta su
upućena lekaru, od kojih je jedan imao epizodu krvarenja. Farmaceuti su sve pacijente
edukovali o važnosti adherence i pravilnoj primeni DOAK i obavešteni su o značaju
posedovanja kartice sa upozorenjima. Rezultati pokazuju neophodnost monitoringa primene
DOAK kod pacijenata ≥65 godina sprovođenjem standardizovane farmaceutske usluge na
primarnom nivou zdravstvene zaštite., The use of direct oral anticoagulants (DOACs) in older patients carries a higher risk of
both thromboembolic events and anticoagulant-associated bleeding, in comparison to
younger patients. The aim of this study was to identify drug-related problems (DRPs) and
pharmacists’ interventions related to DOACs. A prospective survey was conducted at
Pharmacy Kragujevac from 2019 to 2022. Data were obtained for patients aged ≥65 with
DOACs prescription, using a questionnaire that was filled out during a conversation with the
patient. The study included 78 patients, aged 71±8 years, 68% of whom were men. On
average, patients had 3±1 diagnoses and 5±2 medications. Apixaban was used by 44%,
rivaroxaban 31%, dabigatran 25%. Atrial fibrillation was present in 59% and deep vein
thrombosis in 41%. A total of 102 DRPs were detected: inappropriate drug use in 24% (e.g.
taking rivaroxabane without food, opening dabigatran capsules), adherence in 38%, low
dose in 12%, high dose in 9%, while potential interactions were present in 41%. Among the
significant risk factors, 23% had unstable blood pressure, 33% were not informed about the
importance of renal function monitoring during the drug use, and one patient had low
hemoglobin level. Two patients were referred to a doctor, one of whom had an episode of
bleeding. Pharmacists educated all the patients about the importance of adherence, proper
application of DOACs and the importance of DOACs alert card. The results demonstrate the
necessity of monitoring the use of DOACs in elderly patients by implementing standardized
pharmaceutical services at the primary level of health care.",
publisher = "Savez farmaceutskih udruženja Srbije (SFUS)",
journal = "Arhiv za farmaciju",
title = "Značaj monitoringa primene direktnih oralnih antikoagulanasa kod starijih pacijenata u apotekama javnog tipa u Srbiji, Importance of monitoring the use of direct oral anticoagulants in older patients in community pharmacies in Serbia",
volume = "72",
number = "4 Suplement",
pages = "S270-S271-S270",
url = "https://hdl.handle.net/21.15107/rcub_farfar_4393"
}

Anđelković, J., Kovačević, M.,& Miljković, B.. (2022). Značaj monitoringa primene direktnih oralnih antikoagulanasa kod starijih pacijenata u apotekama javnog tipa u Srbiji. in Arhiv za farmaciju
Savez farmaceutskih udruženja Srbije (SFUS)., 72(4 Suplement), S270-S271.
https://hdl.handle.net/21.15107/rcub_farfar_4393

Anđelković J, Kovačević M, Miljković B. Značaj monitoringa primene direktnih oralnih antikoagulanasa kod starijih pacijenata u apotekama javnog tipa u Srbiji. in Arhiv za farmaciju. 2022;72(4 Suplement):S270-S271.
https://hdl.handle.net/21.15107/rcub_farfar_4393 .

Anđelković, Jasna, Kovačević, Milena, Miljković, Branislava, "Značaj monitoringa primene direktnih oralnih antikoagulanasa kod starijih pacijenata u apotekama javnog tipa u Srbiji" in Arhiv za farmaciju, 72, no. 4 Suplement (2022):S270-S271,
https://hdl.handle.net/21.15107/rcub_farfar_4393 .

TY  - CONF
AU  - Anđelković, Jasna
AU  - Milijić Petrović, Valentina
AU  - Marković, Mirjana
AU  - Pavlović, Dragana
AU  - Buha-Đorđević, Aleksandra
AU  - Popović, Ivana
AU  - Stojkov, Svetlana
AU  - Gigov, Slobodan
AU  - Drenić, Dušan
PY  - 2022
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4528
AB  - This paper presents a set of recommendations that can contribute to the improvement
of the pharmacy business. They resulted from a series of professional meetings and a
collection of opinions from masters of pharmacy employed in various health care institutions
in the Republic of Serbia. The general recommendation would imply strict compliance with
existing laws (Law on Medicines and Medical Devices (1), Law on Health Care (2)), but also
the adoption of the Law on Pharmacy, following the example of countries with developed
pharmacy practice. Individual key provisions that would bring improvement of pharmacy
and quality pharmaceutical services to patients in the short term are the mandatory
presence of at least one licensed pharmacist during the entire working hours in each
pharmacy, as well as compliance and control of prescription and over-the-counter medicines.
In the long term, strengthening national regulatory bodies in the field of medicines and
medical devices is important for improving the quality, safety, and efficacy of medicines and
the issuance and application of therapy. According to all standards, these jobs should be
entrusted exclusively to masters of pharmacy, and in certain cases to appropriate pharmacy
specialists. Development of specific clinical skills and introduction of additional services,
such as vaccination and disposal of pharmaceutical waste, would significantly contribute to
resource savings and contribute to the health system.
AB  - Ovaj rad predstavlja skup preporuka koje mogu doprineti poboljšanju apotekarske
delatnosti, a koje su proistekle iz niza stručnih sastanaka i prikupljanja mišljenja od
magistara farmacije zaposlenih u različitim zdravstvenim ustanovama u Republici Srbiji.
Opšta preporuka bi podrazumevala strogo poštovanje postojećih zakona (Zakona o lekovima
i medicinskim sredstavima (1), Zakon o zdravstvenoj zaštiti (2)), ali i donošenje Zakona o
apotekarskoj delatnosti, po ugledu na države sa razvijenom apotekarskom praksom.
Pojedinačne ključne odredbe koje bi u kratkom vremenskom roku donele unapređenje
apotekarske delatnosti i kvalitetne farmaceutske usluge ka pacijentima su obavezno
prisustvo najmanje jednog diplomiranog farmaceuta sa licencom tokom celokupnog radnog
vremena u svakoj apoteci, kao i poštovanje i kontrola režima izdavanja lekova na recept i
lekova bez recepta. Na dugi rok, jačanje nacionalnih regulatornih tela u oblasti lekova i
medicinskih sredstava je značajno radi poboljšanja kvaliteta, bezbednosti i efikasnosti lekova
i izdavanja i primene terapije. Ovi poslovi bi prema svim standardima morali biti povereni
isključivo magistrima farmacije, a u određenim slučajevima i odgovarajućim specijalistima
farmacije. Razvoj specifičnih kliničkih veština i uvođenje dodatnih usluga, kao što su npr.
vakcinacija i zbrinjavanje farmaceutskog otpada, bi značajno doprineli uštedama resursa i
doprineli zdravstvenom sistemu u celini.
PB  - Savez farmaceutskih udruženja Srbije (SFUS)
C3  - Arhiv za farmaciju
T1  - Development of pharmacy activity in Serbia - what do we need?
T1  - Razvoj apotekarske delatnosti u srbiji‐ šta nam je potrebno?
VL  - 72
IS  - 4 suplement
SP  - S284
EP  - S285
UR  - https://hdl.handle.net/21.15107/rcub_farfar_4528
ER  - 

@conference{
author = "Anđelković, Jasna and Milijić Petrović, Valentina and Marković, Mirjana and Pavlović, Dragana and Buha-Đorđević, Aleksandra and Popović, Ivana and Stojkov, Svetlana and Gigov, Slobodan and Drenić, Dušan",
year = "2022",
abstract = "This paper presents a set of recommendations that can contribute to the improvement
of the pharmacy business. They resulted from a series of professional meetings and a
collection of opinions from masters of pharmacy employed in various health care institutions
in the Republic of Serbia. The general recommendation would imply strict compliance with
existing laws (Law on Medicines and Medical Devices (1), Law on Health Care (2)), but also
the adoption of the Law on Pharmacy, following the example of countries with developed
pharmacy practice. Individual key provisions that would bring improvement of pharmacy
and quality pharmaceutical services to patients in the short term are the mandatory
presence of at least one licensed pharmacist during the entire working hours in each
pharmacy, as well as compliance and control of prescription and over-the-counter medicines.
In the long term, strengthening national regulatory bodies in the field of medicines and
medical devices is important for improving the quality, safety, and efficacy of medicines and
the issuance and application of therapy. According to all standards, these jobs should be
entrusted exclusively to masters of pharmacy, and in certain cases to appropriate pharmacy
specialists. Development of specific clinical skills and introduction of additional services,
such as vaccination and disposal of pharmaceutical waste, would significantly contribute to
resource savings and contribute to the health system., Ovaj rad predstavlja skup preporuka koje mogu doprineti poboljšanju apotekarske
delatnosti, a koje su proistekle iz niza stručnih sastanaka i prikupljanja mišljenja od
magistara farmacije zaposlenih u različitim zdravstvenim ustanovama u Republici Srbiji.
Opšta preporuka bi podrazumevala strogo poštovanje postojećih zakona (Zakona o lekovima
i medicinskim sredstavima (1), Zakon o zdravstvenoj zaštiti (2)), ali i donošenje Zakona o
apotekarskoj delatnosti, po ugledu na države sa razvijenom apotekarskom praksom.
Pojedinačne ključne odredbe koje bi u kratkom vremenskom roku donele unapređenje
apotekarske delatnosti i kvalitetne farmaceutske usluge ka pacijentima su obavezno
prisustvo najmanje jednog diplomiranog farmaceuta sa licencom tokom celokupnog radnog
vremena u svakoj apoteci, kao i poštovanje i kontrola režima izdavanja lekova na recept i
lekova bez recepta. Na dugi rok, jačanje nacionalnih regulatornih tela u oblasti lekova i
medicinskih sredstava je značajno radi poboljšanja kvaliteta, bezbednosti i efikasnosti lekova
i izdavanja i primene terapije. Ovi poslovi bi prema svim standardima morali biti povereni
isključivo magistrima farmacije, a u određenim slučajevima i odgovarajućim specijalistima
farmacije. Razvoj specifičnih kliničkih veština i uvođenje dodatnih usluga, kao što su npr.
vakcinacija i zbrinjavanje farmaceutskog otpada, bi značajno doprineli uštedama resursa i
doprineli zdravstvenom sistemu u celini.",
publisher = "Savez farmaceutskih udruženja Srbije (SFUS)",
journal = "Arhiv za farmaciju",
title = "Development of pharmacy activity in Serbia - what do we need?, Razvoj apotekarske delatnosti u srbiji‐ šta nam je potrebno?",
volume = "72",
number = "4 suplement",
pages = "S284-S285",
url = "https://hdl.handle.net/21.15107/rcub_farfar_4528"
}

Anđelković, J., Milijić Petrović, V., Marković, M., Pavlović, D., Buha-Đorđević, A., Popović, I., Stojkov, S., Gigov, S.,& Drenić, D.. (2022). Development of pharmacy activity in Serbia - what do we need?. in Arhiv za farmaciju
Savez farmaceutskih udruženja Srbije (SFUS)., 72(4 suplement), S284-S285.
https://hdl.handle.net/21.15107/rcub_farfar_4528

Anđelković J, Milijić Petrović V, Marković M, Pavlović D, Buha-Đorđević A, Popović I, Stojkov S, Gigov S, Drenić D. Development of pharmacy activity in Serbia - what do we need?. in Arhiv za farmaciju. 2022;72(4 suplement):S284-S285.
https://hdl.handle.net/21.15107/rcub_farfar_4528 .

Anđelković, Jasna, Milijić Petrović, Valentina, Marković, Mirjana, Pavlović, Dragana, Buha-Đorđević, Aleksandra, Popović, Ivana, Stojkov, Svetlana, Gigov, Slobodan, Drenić, Dušan, "Development of pharmacy activity in Serbia - what do we need?" in Arhiv za farmaciju, 72, no. 4 suplement (2022):S284-S285,
https://hdl.handle.net/21.15107/rcub_farfar_4528 .